EU Accelerated Assessment Tracker
Novartis Fails To Secure Fast-Track Review For Trabecta
Novartis is one of the latest companies to fail in its attempt to have a marketing authorization application fast-tracked at the European Medicines Agency. There was better news for BioMarin.